Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Serina Therapeutics Inc. (NYSE : SER) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
Quote
| Last: | $1.98 |
|---|---|
| Change Percent: | 2.59% |
| Open: | $1.86 |
| Close: | $1.93 |
| High: | $2 |
| Low: | $1.835 |
| Volume: | 51,555 |
| Last Trade Date Time: | 06/16/2026 01:47:31 pm |
Stock Data
| Market Cap: | $22,649,684 |
|---|---|
| Float: | 7,301,827 |
| Insiders Ownership: | 2.9% |
| Institutions: | 11 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.serinatx.com |
| Country: | US |
| City: | Huntsville |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Serina Therapeutics Inc. (NYSE: SER).
